VION Biosciences Acquires Ansh Labs

VION Biosciences Acquires BioAssay Systems

February 5, 2025

Biotechnology

VION Biosciences acquired Hayward, California–based BioAssay Systems in January 2025 as the fourth add-on for its life‑science products platform. The deal adds BioAssay Systems’ enzymatic and high‑throughput assay kits, reagents and analytical services to VION’s proprietary product portfolio to accelerate capability expansion for drug discovery and life‑science research customers.

Iron Path Capital-backed VION Biosciences Acquires Aldon Corporation

August 7, 2023

Manufacturing

Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.

VION Biosciences Acquires Echelon Biosciences

August 22, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.

Versant Diagnostics (Iron Path Capital) Acquires Addison Central Pathology

October 18, 2021

Healthcare Services

Versant Diagnostics, a physician services platform backed by private equity firm Iron Path Capital, announced its formation and the addition of Addison Central Pathology to create one of the largest independent anatomic pathology groups in the Midwest. The partnership—led by physician founders and Iron Path Capital—aims to scale a technology-forward, physician-led pathology platform focused on digital pathology and precision medicine.

Veranex Acquires Fusion Biotec

December 13, 2022

Medical Devices

Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.

Lightbeam Health Solutions Acquires Jvion Operating Assets

May 31, 2022

Healthcare Services

Lightbeam Health Solutions has entered into an asset purchase agreement to acquire the operating assets related to Jvion, including its AI-enabled prescriptive analytics and social determinants of health (SDoH) solutions. The acquisition expands Lightbeam's population health management and SDoH capabilities, combining Jvion's clinical intelligence with Lightbeam's analytics and RPM offerings to enhance value-based care for payers and providers.